HLA-E Antikörper
Kurzübersicht für HLA-E Antikörper (ABIN3200238)
Target
Alle HLA-E Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Reacts with the native surface-expressed human HLA-E, but not with the denaturated heavy chain of HLA-E
-
Kreuzreaktivität (Details)
- May cross-react weakly with HLA-A3, A11, -A24, -A32, -B7, -B8, -B15, -B27, -B35, -B44, -B54, -C3, -C4, -C5 and -C7. Cross-reacts with monkey counterparts.
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Recombinant human HLA-E refolded with beta2-microglobulin and peptide.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, Sodium azide 15 mM
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
-
- HLA-E (HLA Class I Histocompatibility Antigen, alpha Chain E (HLA-E))
-
Andere Bezeichnung
- HLA-E
-
Gen-ID
- 3133
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-